BIOMAT Database Logo BIOMAT Database Logo

Gynecomastia in HIV-infected patients receiving antiretroviral therapy. 2003

Teresa García-Benayas, and Francisco Blanco, and Luz Martín-Carbonero, and Eulalia Valencia, and Ana Barrios, and Juan González-Lahoz, and Vincent Soriano
Service of Infectious Diseases, Hospital Carlos III, Instituto de Salud Carlos III, 28035 Madrid, Spain.

Thirty-four HIV-positive men with gynecomastia were seen in an HIV outclinic during a 20-month period (incidence of 2.4 cases/100 patients receiving HAART per year). It developed mainly in subjects having good immunologic and virologic status, after an average of 3 years of HAART. No hormone abnormalities were found, or association with specific drugs. Although initially unilateral, more than half of cases progressed to bilateral gynecomastia. Spontaneous resolution occurred in most subjects with 12 months without modifying therapy.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D006177 Gynecomastia Enlargement of the BREAST in the males, caused by an excess of ESTROGENS. Physiological gynecomastia is normally observed in NEWBORNS; ADOLESCENT; and AGING males. Adolescent Gynecomastia,Infant Gynecomastia,Male Breast Enlargement,Newborn Gynecomastia,Breast Enlargement, Male,Enlargement, Male Breast,Gynecomastia, Adolescent,Gynecomastia, Infant,Gynecomastia, Newborn
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D023241 Antiretroviral Therapy, Highly Active Drug regimens, for patients with HIV INFECTIONS, that aggressively suppress HIV replication. The regimens usually involve administration of three or more different drugs including a protease inhibitor. Combination Antiretroviral Therapy,HAART,Highly Active Antiretroviral Therapy,Antiretroviral Therapies, Combination,Antiretroviral Therapy, Combination,Combination Antiretroviral Therapies,Therapies, Combination Antiretroviral,Therapy, Combination Antiretroviral

Related Publications

Teresa García-Benayas, and Francisco Blanco, and Luz Martín-Carbonero, and Eulalia Valencia, and Ana Barrios, and Juan González-Lahoz, and Vincent Soriano
Diabetes mellitus in HIV-infected patients receiving antiretroviral therapy.
October 2013, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
Teresa García-Benayas, and Francisco Blanco, and Luz Martín-Carbonero, and Eulalia Valencia, and Ana Barrios, and Juan González-Lahoz, and Vincent Soriano
Management of dyslipidaemia in HIV-infected patients receiving antiretroviral therapy.
October 2004, Antiviral therapy,
Teresa García-Benayas, and Francisco Blanco, and Luz Martín-Carbonero, and Eulalia Valencia, and Ana Barrios, and Juan González-Lahoz, and Vincent Soriano
Sustained viral suppression in HIV-infected patients receiving antiretroviral therapy.
July 2012, JAMA,
Teresa García-Benayas, and Francisco Blanco, and Luz Martín-Carbonero, and Eulalia Valencia, and Ana Barrios, and Juan González-Lahoz, and Vincent Soriano
Anemia in HIV-infected patients receiving highly active antiretroviral therapy.
January 2002, Journal of acquired immune deficiency syndromes (1999),
Teresa García-Benayas, and Francisco Blanco, and Luz Martín-Carbonero, and Eulalia Valencia, and Ana Barrios, and Juan González-Lahoz, and Vincent Soriano
Lactic acidosis in HIV-I infected patients receiving antiretroviral therapy.
August 2004, The Journal of the Association of Physicians of India,
Teresa García-Benayas, and Francisco Blanco, and Luz Martín-Carbonero, and Eulalia Valencia, and Ana Barrios, and Juan González-Lahoz, and Vincent Soriano
QT dispersion in HIV-infected patients receiving combined antiretroviral therapy.
November 2014, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc,
Teresa García-Benayas, and Francisco Blanco, and Luz Martín-Carbonero, and Eulalia Valencia, and Ana Barrios, and Juan González-Lahoz, and Vincent Soriano
Nitric oxide levels in HIV-infected, untreated patients and HIV-infected patients receiving antiretroviral therapy.
April 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Teresa García-Benayas, and Francisco Blanco, and Luz Martín-Carbonero, and Eulalia Valencia, and Ana Barrios, and Juan González-Lahoz, and Vincent Soriano
Alternative therapy use in HIV-infected patients receiving highly active antiretroviral therapy.
October 2002, International journal of STD & AIDS,
Teresa García-Benayas, and Francisco Blanco, and Luz Martín-Carbonero, and Eulalia Valencia, and Ana Barrios, and Juan González-Lahoz, and Vincent Soriano
[MEDICO-SOCIAL CHARACTERISTIC OF HIV-INFECTED PATIENTS RECEIVING ANTIRETROVIRAL THERAPY].
January 2015, Klinicheskaia meditsina,
Teresa García-Benayas, and Francisco Blanco, and Luz Martín-Carbonero, and Eulalia Valencia, and Ana Barrios, and Juan González-Lahoz, and Vincent Soriano
Hypertension in HIV-Infected Patients Receiving Antiretroviral Therapy in Northeast Ethiopia.
January 2019, International journal of hypertension,
Copied contents to your clipboard!